Key Takeaway
The paper supports testing FKRP early in appropriate LGMD workups because clinically mild and more severe courses can exist in the same broad diagnostic space.
Evidence Summary
Genotype-phenotype paper showing that FKRP-related LGMD can be present and clinically varied in North American cohorts, not only in founder populations from Northern Europe.
Citation: Kang PB, Feener CA, Estrella E, et al. LGMD2I in a North American population. BMC Musculoskelet Disord. 2007;8:115.
Key Takeaway
The paper supports testing FKRP early in appropriate LGMD workups because clinically mild and more severe courses can exist in the same broad diagnostic space.
Primary Sources
Primary indexed record for the paper summary on this page.
Publisher DOI landing page.
Related Content
Paper Summary
Review article mapping FKRP biology, disease mechanisms, model systems, and the treatment approaches that were emerging by 2021.
Glossary
The relationship between a genetic variant pattern and the clinical features seen in a person or group.
Guide
FKRP is a gene involved in alpha-dystroglycan glycosylation. Pathogenic variants in FKRP can cause a spectrum of muscular dystrophy-dystroglycanopathies, ranging from severe congenital presentations to later-onset limb-girdle disease.